AutoRx.
Physician-led GLP-1, built for scale.

Six-month physician authorization. One required visit at the start. Automated titration following an evidence-based schedule. Continuous physician access throughout. Designed so weight loss brands can offer competitive monthly economics to patients without cutting clinical oversight.

Request the program brief

Talk to the AutoRx team

The full protocol design is shared with verified prospects only.

What it is.

AutoRx is a structured six-month GLP-1 weight loss protocol. One initial physician consult authorizes six months of treatment, with a clinical check-in at month three. The initial consult is prepaid at the start of the program. Between the consult and the check-in, patients have continuous access to their physician through secure messaging. Titration follows a clinically validated schedule that the physician customizes per patient at intake and adjusts in real time as the patient progresses.

The structure exists because the standard monthly visit model creates friction that hurts adherence, hurts conversion, and concentrates physician work in places that do not clinically need it. AutoRx puts physician time where the clinical evidence says it matters, the initial workup and the three-month check, and uses automated workflows for everything in between.

Titration is clinician-set,
not algorithmic.

Both semaglutide and tirzepatide follow clinically validated dose escalation. The physician sets the schedule per patient at intake based on candidacy, comorbidities, and tolerability profile, and adjusts in real time as the patient progresses. Dose holds and step backs trigger on physician judgment, not on a static algorithm.

The specific cadence we use by default, the dose hold rules, the step back logic, and the partner economics are shared with verified prospects only. We do not publish that detail on the public site because we would rather keep the protocol design out of competitor hands.

Request the AutoRx brief →

The patient experience,
month by month.

Month 0. Intake and consult.

Patient completes the clinical questionnaire and identity verification. Physician reviews the intake, conducts the initial consult (synchronous where required by state law, asynchronous where permitted), confirms appropriate candidacy, and writes the six-month authorization. First medication shipment is released to the pharmacy.

Months 1 and 2. Monthly fulfillment.

Medication ships monthly per the titration schedule. Patient has continuous access to their physician through secure messaging. Side effects, tolerability questions, and dose concerns are answered in real time. No additional visit fees during this window.

Month 3. Required clinical check in.

Physician reviews progress: weight trend, side effects, lab work if applicable, and patient reported outcomes. Confirms continued candidacy, adjusts the titration plan as needed, and sets the maintenance dose. This visit is prepaid at intake and required by the protocol.

Months 4-6. Maintenance.

Patient receives monthly fulfillment at the maintenance dose. Continuous physician messaging remains available. Side effect monitoring, dose hold protocols, and step back rules continue to run in the background.

Month 6. Re authorization.

Patient completes a follow up clinical review. Physician decides whether to continue treatment, transition to a different protocol, or step the patient out. If continued, a new six-month authorization is issued and the cycle restarts.

How AutoRx pricing
is structured.

One prepayment at intake covers the initial physician consult. The three-month clinical check-in is included at no additional charge. Medication facilitation and shipment are separate line items, priced pass through with the underlying cost visible to you. The structure is designed so partners can offer a competitive monthly price point to patients while maintaining the required clinical oversight, without forcing physicians to do a billable visit every month that the clinical evidence does not require.

We do not publish the actual numbers because pricing varies by protocol mix, medication source (compounded versus branded), pharmacy choice, and expected volume. Every number is shared on the scoping call, before integration begins.

How pricing is structured →

The compliance rationale.

A six month authorization anchored by an initial consult and a structured month-three clinical check-in is not a workaround. It is a clinically appropriate structure for chronic weight management, supported by the prescribing guidance for GLP-1 receptor agonists and consistent with how chronic disease management works outside telehealth. The initial workup is where physicians do most of their cognitive work: history, candidacy, contraindications, comorbidities, and the dosing plan. The three month check is where physicians verify response and adjust. Between those, ongoing monitoring through structured messaging and physician oversight is appropriate and standard.

What makes AutoRx clinically distinct from the models that have drawn regulatory scrutiny is the level of physician engagement throughout. Every patient has a named physician. Messaging is read and replied to by that physician. Dose escalations follow the schedule the physician set, with hold and step back protocols that trigger if the patient reports side effects. Patients can request a visit at any time, and the protocol requires one at month three. This is not a pill mill model with a doctor's signature attached. It is physician led chronic care delivered through a structure that matches how the medicine actually works.

Want the full
AutoRx brief?

The complete protocol design, side effect monitoring rules, dose hold logic, and partner economics go only to verified prospects.

Request the program brief

AutoRx.Physician-led GLP-1, built for scale.

What it is.

Titration is clinician-set,not algorithmic.

The patient experience,month by month.

How AutoRx pricingis structured.